curasan AG

curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company specializes in biomimetic bone regeneration materials which are used in dental field, jaw and facial surgery, and orthopedics and spinal column surgery. Its products include CERASORB, a bone replacement material; stypro, a sterile sponge for hemostasis; Curavisc, a hyaluronic acid for the treatment of osteoarthritis; Osbone, a synthetic open?cell cancellous bone graft material for filling bone defects and augmentation of the atrophied alveolar ridge; foils and membranes for use in dental and oral surgeries; and accessories, such as fixation systems for use in bone augmentation surgery. The company was founded in 1988 and is based in Kleinostheim, Germany.